Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 22, Issue 8, Pages 1061-1070
Publisher
SAGE Publications
Online
2015-10-14
DOI
10.1177/1352458515608961
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of Nonmyeloablative Hematopoietic Stem Cell Transplantation With Neurological Disability in Patients With Relapsing-Remitting Multiple Sclerosis
- (2015) Richard K. Burt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PML in a Patient without Severe Lymphocytopenia Receiving Dimethyl Fumarate
- (2015) Dennis J. Nieuwkamp et al. NEW ENGLAND JOURNAL OF MEDICINE
- PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate
- (2015) Thorsten Rosenkranz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of dimethyl fumarate on lymphocyte subsets
- (2015) Regina Berkovich et al. Multiple Sclerosis and Related Disorders
- Peripheral Blood T Cell Dynamics Predict Relapse in Multiple Sclerosis Patients on Fingolimod
- (2015) Zi-Ye Song et al. PLoS One
- Daclizumab (anti-CD25) in multiple sclerosis
- (2014) Nikolai Pfender et al. EXPERIMENTAL NEUROLOGY
- The Plasmacytoid Dendritic Cell as the Swiss Army Knife of the Immune System: Molecular Regulation of Its Multifaceted Functions
- (2014) Julien J. Karrich et al. JOURNAL OF IMMUNOLOGY
- Dimethyl fumarate associated lymphopenia in clinical practice
- (2014) Erin E Longbrake et al. Multiple Sclerosis Journal
- CD4+T-cell depletion in HIV infection: mechanisms of immunological failure
- (2013) Afam A. Okoye et al. IMMUNOLOGICAL REVIEWS
- Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis
- (2013) Domenico Plantone et al. JOURNAL OF NEUROIMMUNOLOGY
- Progressive multifocal leukoencephalopathy and idiopathic CD4 lymphocytopenia
- (2013) Manuel Delgado-Alvarado et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- L-Selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients
- (2013) N. Schwab et al. NEUROLOGY
- PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy
- (2013) Bob W. van Oosten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idiopathic CD4 lymphopenia associated with neuroinvasive West Nile disease: Case report and review of the literature
- (2013) Alex McBath et al. Journal of Infection and Public Health
- Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
- (2012) Haiyan Peng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multiple sclerosis
- (2012) Alyssa Nylander et al. JOURNAL OF CLINICAL INVESTIGATION
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD8+ T Cells Primed in the Periphery Provide Time-Bound Immune-Surveillance to the Central Nervous System
- (2011) K. G. Young et al. JOURNAL OF IMMUNOLOGY
- Plasmacytoid Dendritic Cells in Multiple Sclerosis
- (2009) Roberto Lande et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
- (2008) M. Mehling et al. NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started